US Patent Issued to Sangamo Therapeutics on Oct. 27 for "Compositions and methods for producing recombinant AAV" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,475, issued on Oct. 27, was assigned to Sangamo Therapeutics Inc. (Richmond, Calif.).

"Compositions and methods for producing recombinant AAV" was invented by Alex Michael Ward (El Cerrito, Calif.), Hung Tran (San Francisco), Andrea J. Kang (San Carlos, Calif.), Tzu-Hung Chen (Berkeley, Calif.) and Richard T. Surosky (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are nucleic acid constructs, host insect cells, and methods for producing recombinant AAV capsids with high potency at high yield."

The patent was filed on Dec. 4, 2020, under Application No. 17/777,723.

*For further information, including images, charts a...